Results 1 to 10 of about 41,675 (347)

Anesthetic management for withdrawal from a right ventricular assist device and Fontan procedure in a patient with an implantable left ventricular assist device for fulminant cardiomyopathy [PDF]

JA Clinical Reports, 2023
Background We herein report the anesthetic management for extracardiac conduit–total cavopulmonary connection (EC-TCPC) for weaning from an extracorporeal right ventricular assist device (RVAD) in a patient with an implantable left ventricular assist ...
Naka Kida, Masahiro Morinaga, Naoki Tadokoro, Takuma Maeda, Yoshihiko Onishi   +4 more
doaj   +4 more sources

Percutaneous right ventricular assist device, rapid employment in right ventricular failure during septic shock [PDF]

Critical Care, 2020
Ignazio Condello
doaj   +4 more sources

Hybrid closure of ventricular septal defect and implantation of systemic right ventricular assist device [PDF]

ESC Heart Failure, 2022
A 50‐year‐old female patient was readmitted with refractory systemic right ventricular failure. The patient underwent a Mustard procedure during childhood for transposition of the great arteries.
Jerome Soquet, Ali Houeijeh, Marjorie Richardson, Eleonore Hebbar, Guy Vaksmann, Jean‐Benoit Baudelet, Mouhamed Djahoum Moussa, Andre Vincentelli   +7 more
doaj   +2 more sources

Different ECLS Pump Configurations for Temporary Right Ventricular Assist Device in LVAD Patients: A Retrospective Case–Control Study [PDF]

Life
Background: Acute right ventricular failure is a critical complication after left ventricular assist device (LVAD) implantation, often managed with a temporary paracorporeal right ventricular assist device (RVAD). This study examined three extracorporeal
Dragan Opacic, Christian Klüß, Darko Radakovic, Georges El-Hachem, Tobias Becker, Markus Rudloff, Volker Lauenroth, Marcus-André Deutsch, Claudio Velasquez-Silva, Henrik Fox, René Schramm, Michiel Morshuis, Jan F. Gummert, Sebastian V. Rojas   +13 more
doaj   +2 more sources

Predicting right ventricular failure after left ventricular assist device implant: A novel approach [PDF]

ESC Heart Failure
Aims Right ventricular (RV) failure (RVF) after left ventricular assist device (LVAD) implant is an important cause of morbidity and mortality. Modern, data‐driven approaches for defining and predicting RVF have been under‐utilized.
Carissa E. Livingston, Dale Kim, Lacey Serletti, Andrea Jin, Sriram Rao, Michael V. Genuardi, Eliot G. Peyster   +6 more
doaj   +2 more sources

Right ventricular functional assessment by three-dimensional transesophageal echocardiography is useful for withdrawal from a right ventricular assist device: a case report [PDF]

JA Clinical Reports, 2017
Right ventricular assist device (RVAD) implantation is one type of surgical treatment used for right heart failure. It is important to assess right ventricular (RV) function precisely when RVAD withdrawal is considered. Although assessment of RV function
Hiroki Taenaka, Tatsuyuki Imada, Ryuichiro Abe, Akinori Uchiyama, Yuji Fujino   +4 more
doaj   +2 more sources

Comprehensive Monitoring in Patients With Dual Lumen Right Atrium to Pulmonary Artery Right Ventricular Assist Device. [PDF]

ASAIO J, 2022
Usman AA, Spelde AE, Ibrahim M, Cevasco M, Bermudez C, MacKay E, MacKay E, Khandhar S, Szeto W, Vernick W, Gutsche J.   +10 more
europepmc   +3 more sources

Single-Center Experience with the HeartMate 3 Assist Device in Pediatric Patients with Cardiomyopathy [PDF]

Medicina
Background and Objectives: The use of the HeartMate 3 (HM3) ventricular assist device (VAD) as a bridge to transplant is rising notably in pediatric patients with end-stage heart disease.
Michal Hulman, Panagiotis Artemiou, Danielle Stuschkova, Stefan Durdik, Matej Nosal, Zuzana Hrubsova, Lubica Kovacikova, Pavol Kunovsky, Martin Zahorec, Matus Kovac, Ivo Gasparovic   +10 more
doaj   +2 more sources

Percutaneous right ventricular assist device–supported ventricular tachycardia ablation in a patient with severe right ventricular dysfunction [PDF]

HeartRhythm Case Reports, 2020
Martin Aguilar, MD, PhD, Allison L. Tsao, MD, Kevin J. Croce, MD, PhD, William Sauer, MD, FHRS, David A. Morrow, MD, MPH, Usha B. Tedrow, MD, MSc, FHRS   +5 more
doaj   +2 more sources

A case report: corheart 6 biventricular assist device therapy for end-stage heart failure in dilated cardiomyopathy [PDF]

Frontiers in Cardiovascular Medicine
Approximately one-third of patients with end-stage heart failure (ESHF) experience biventricular failure. Left ventricular assist devices (LVADs) are employed as a salvage therapy for individuals with advanced heart failure.
Qiuju Ding, Cheng Chen, Zhenjun Xu, Ning Zhang, Jun Pan, Min Ge   +5 more
doaj   +2 more sources